Search Results - Richard Görlick

Refine Results
  1. 1
    Osteosarcoma

    Osteosarcoma by Richard Görlick, Chand Khanna

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Activation of the RAF/Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Mediates Apoptosis Induced by Chelerythrine in Osteosarcoma

    Activation of the RAF/Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Mediates Apoptosis Induced by Chelerythri... by Rui Yang, Sajida Piperdi, Richard Görlick

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

    Osteosarcoma: Current Treatment and a Collaborative Pathway to Success by Michael S. Isakoff, Stefan Bielack, Paul S. Meltzer, Richard Görlick

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Future directions in the treatment of osteosarcoma

    Future directions in the treatment of osteosarcoma by Michael W. Bishop, Katherine A. Janeway, Richard Görlick

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Mesenchymal Chondrosarcoma: Clinicopathologic Study of 20 Cases

    Mesenchymal Chondrosarcoma: Clinicopathologic Study of 20 Cases by Rachel Shakked, David S. Geller, Richard Görlick, Howard D. Dorfman

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    A Review of Targeted Therapies Evaluated by the Pediatric Preclinical Testing Program for Osteosarcoma

    A Review of Targeted Therapies Evaluated by the Pediatric Preclinical Testing Program for Osteosarcoma by Valerie B. Sampson, Richard Görlick, Davida Kamara, E. Anders Kolb

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Biology and Therapeutic Advances for Pediatric Osteosarcoma

    Biology and Therapeutic Advances for Pediatric Osteosarcoma by Neyssa Marina, Mark C. Gebhardt, Lisa A. Teot, Richard Görlick

    Published 2004
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Resistance Mechanisms to Methotrexate in Tumors

    Resistance Mechanisms to Methotrexate in Tumors by Joseph R. Bertino, Erdem Göker, Richard Görlick, W. W. Li, Debabrata Banerjee

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Children's Oncology Group's 2013 blueprint for research: Bone tumors

    Children's Oncology Group's 2013 blueprint for research: Bone tumors by Richard Görlick, Katherine A. Janeway, Stephen L. Lessnick, R. Lor Randall, Neyssa Marina

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Hypoxia Markers in Human Osteosarcoma: An Exploratory Study

    Hypoxia Markers in Human Osteosarcoma: An Exploratory Study by Hiroo Mizobuchi, José Manuel García-Castellano, Shaji Philip, John H. Healey, Richard Görlick

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Genetically transforming human mesenchymal stem cells to sarcomas

    Genetically transforming human mesenchymal stem cells to sarcomas by Nan Li, Rui Yang, Wendong Zhang, Howard D. Dorfman, Pulivarthi H. Rao, Richard Görlick

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Cell surface receptor expression patterns in osteosarcoma

    Cell surface receptor expression patterns in osteosarcoma by Sheref E. Hassan, Mikhail Bekarev, Mimi Kim, Juan Lin, Sajida Piperdi, Richard Görlick, David S. Geller

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines

    IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines by Zhiliang Jia, Dristhi Ragoonanan, Kris M. Mahadeo, Jonathan Gill, Richard Görlick, Elizabeth Shpal, Shulin Li

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

    Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma by Michael Roth, Marissa Linkowski, John Tarim, Sajida Piperdi, Rebecca Sowers, David S. Geller, Jonathan Gill, Richard Görlick

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    <i>FCGR2A</i> Polymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor

    <i>FCGR2A</i> Polymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor by Nai‐Kong V. Cheung, Rebecca Sowers, Andrew J. Vickers, Irene Y. Cheung, Brian H. Kushner, Richard Görlick

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma

    Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma by Vincent Poon, Michael Roth, Sajida Piperdi, David S. Geller, Jonathan Gill, Erin R. Rudzinski, Douglas S. Hawkins, Richard Görlick

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos‐2 cells

    Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos‐2 cells by Yi Guo, Xiaolin Zi, Zach Koontz, Alison Kim, Jun Xie, Richard Görlick, Randall F. Holcombe, Bang H. Hoang

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Defective Transport Is a Common Mechanism of Acquired Methotrexate Resistance in Acute Lymphocytic Leukemia and Is Associated With Decreased Reduced Folate Carrier Expression

    Defective Transport Is a Common Mechanism of Acquired Methotrexate Resistance in Acute Lymphocytic Leukemia and Is Associated With Decreased Reduced Folate Carrier Expression by Richard Görlick, Erdem Göker, Tanya Trippett, Peter G. Steinherz, Y Elisseyeff, Madhu Mazumdar, Wayne F. Flintoff, Joseph R. Bertino

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    R1507, a fully human monoclonal antibody targeting IGF‐1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts

    R1507, a fully human monoclonal antibody targeting IGF‐1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts by E. Anders Kolb, Davida Kamara, Wendong Zhang, Juan Lin, Pooja Hingorani, Laurence H. Baker, Peter J. Houghton, Richard Görlick

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells

    A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells by Min Hwa Shin, Yunlong He, Eryney Marrogi, Sajida Piperdi, Ling Ren, Chand Khanna, Richard Görlick, Chengyu Liu, Jing Huang

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: